Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Genetic Sleuthing

September 16, 2015 7:30 am | by Harvard Gazette | News | Comments

Scientists fighting last year’s outbreak of Ebola used the power of genetic sequencing to unlock the secrets of the deadly virus. Read more...


Mylan Opens $27.14B Hostile Bid for Perrigo

September 16, 2015 7:15 am | by The Associated Press | News | Comments

Perrigo's board had rejected several offers from Mylan and has said it is confident its shareholders would reject Mylan's offer. Read more...


Drug Prevents Type 1 Diabetes In Mice

September 15, 2015 11:45 am | by Stanford University | News | Comments

A compound that blocks the synthesis of hyaluronan, a substance generally found in in all body tissue, protected mice from getting Type 1 diabetes. The compound is already approved in Europe and Asia for the treatment of gallbladder disease. Read more...


XenoPort Shares Dive After Psoriasis Drug Study Results

September 15, 2015 11:34 am | by Stephanie Guzowski, Editor | News | Comments

Shares of Santa Clara, CA-based XenoPort were down 25 percent by midmorning Tuesday after the company announced positive preliminary results from a Phase 2 clinical trial of its oral psoriasis drug.  Although the biotech said it expects to begin Phase 3 trials of its drug, XP23829, in 2016, a high rate of gastrointestinal side effects may impede its efforts. Read more...


Repatha Reduced LDL-C by up to 75 Percent Compared With Placebo

September 15, 2015 9:30 am | News | Comments

Amgen Canada Inc. today announced that Health Canada has approved a new cholesterol-lowering medication, RepathaTM (evolocumab). Repatha is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that reduces the liver's ability to remove low-density lipoprotein cholesterol (LDL-C), or "bad" cholesterol, from the blood. Read more...


Crunching Numbers to Combat Cancer

September 15, 2015 9:23 am | by UC San Francisco | News | Comments

UC San Francisco has received a National Cancer Institute grant of $5 million over the next five years to lead a massive effort to integrate the data from all experimental models across all types of cancer. The web-based repository is an important step in moving the fight against cancer toward precision medicine. Read more...


Filling a Void in Stem Cell Therapy

September 15, 2015 9:14 am | by Harvard University | News | Comments

A new porous hydrogel could boost the success of stem-cell-based tissue regeneration. Read more...


Panel Backs Aspirin For Heart Health In Only Certain Adults

September 15, 2015 8:55 am | by Lauren Neergaard, AP Medical Writer | News | Comments

A government task force says a daily low-dose aspirin could help certain people in their 50s and 60s prevent a first heart attack or stroke - and they might get some protection against colon cancer at the same time. Read more...


Why MS Symptoms May Improve as Days Get Shorter

September 15, 2015 8:25 am | by Harvard University | News | Comments

For patients and clinicians alike, it’s long been a mystery: Why do symptoms of multiple sclerosis (MS) seem to get better in the winter and worse in the summer? A group at Brigham and Women’s Hospital (BWH) and collaborators have found an explanation that could lead to a deeper understanding of the disease and more targeted treatment options for patients.

FDA Accepts NDA for First-Ever Digital Medication

September 15, 2015 8:25 am | by Ryan Bushey, Associate Editor | News | Comments

This creation could provide significant assistance in helping to treat behavioral health conditions. Read more...


New Ebola Death Reported in Sierra Leone

September 15, 2015 7:55 am | News | Comments

The announcement marked another setback in ending Ebola transmission in Sierra Leone. Read more...


Bringing Global Health Home

September 15, 2015 7:45 am | by Harvard Gazette | News | Comments

After 5 years, institute outlines recent successes, rising challenges that face everyone. Read more...


New Leukemia Gene Stops Blood Cells 'Growing Up'

September 15, 2015 7:41 am | by University of Manchester | News | Comments

The FOXC1 gene is normally switched on during embryonic development and is needed to turn cells into specialized tissues. Read more...


An Antibody that Can Attack HIV in New Ways

September 15, 2015 7:25 am | by Caltech | News | Comments

The process of HIV infection begins when the virus comes into contact with T cells that carry a particular protein on their surface. Read more...


Sanofi: Combination Diabetes Drug Reaches Target in Second Phase 3 Trial

September 14, 2015 12:36 pm | by Stephanie Guzowski, Editor | News | Comments

Sanofi announced on Monday a second Phase 3 study of its diabetes drug, LixiLan, met its main goal of reducing HbA1c compared with insulin glargine (Lantus) in people with Type 2 diabetes. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.